Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gproan 6-valent HPV VLP vaccine
- Development stage
- Preclinical
- Lead developer
- Gproan Biotech
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Gproan 6-valent HPV VLP vaccine is a prophylactic vaccine candidate developed by Gproan Biotech. It utilizes virus-like particle (VLP) technology to target six specific types of Human Papillomavirus (HPV) that are highly prevalent within the Chinese population. By mimicking the viral structure without containing genetic material, the vaccine aims to induce a robust immune response and the production of neutralizing antibodies to prevent HPV infection and the subsequent development of cervical cancer and other HPV-related diseases. It is currently in the preclinical stage of development.
- Other names
- Gproan hexavalent HPV vaccineGproan 6-valent HPV vaccineGproan6-valent HPV vaccineGproan-6-valent HPV vaccine
02
Targets
HPV L1 (Human papillomavirus L1 capsid protein)
Beyond the preview
Go deeper on Gproan 6-valent HPV VLP vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gproan 6-valent HPV VLP vaccine.